Caixin
Dec 10, 2022 06:00 AM
CHINA

Second China-Made mRNA Covid Shot Approved Overseas

China itself has not authorized any mRNA shots for domestic use, although several clinical trials are underway.
China itself has not authorized any mRNA shots for domestic use, although several clinical trials are underway.

A messenger RNA-based Covid-19 vaccine developed by Chinese biotech firm Stemirna Therapeutics won approval for emergency use in Laos, the second China-made mRNA shot cleared for public inoculation outside the country.

The Laos Food and Drug Department cleared the Stemirna inoculation Thursday for use in people ages 18 and older. The vaccine is designed to protect people against new virus variants including delta and omicron.

You've accessed an article available only to subscribers
VIEW OPTIONS
Share this article
Open WeChat and scan the QR code
NEWSLETTERS
Get our CX Daily, weekly Must-Read and China Green Bulletin newsletters delivered free to your inbox, bringing you China's top headlines.

We ‘ve added you to our subscriber list.

Manage subscription
PODCAST